✦ LIBER ✦

Induction chemotherapy with continuous infusion ifosfamide (IFX) and antracyclin in a high dose chemotherapy with peripheral blood stem cell (PBSC) support program in advanced soft tissue sarcomas (STS)

✍ Scribed by Bergandi, D.; Grosso, F.; Montemurro, F.; Schianca, F.Carnevale; Gerbino, A.; Faggiuolo, R.; Capaldi, A.; Aglietta, M.

Book ID: 122475558
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 60 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(99)81618-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose chemotherapy and autologous pe

High-dose chemotherapy and autologous peripheral blood stem cell transplantation in adult patients with high-risk or advanced Ewing and soft tissue sarcoma

✍ M. Engelhardt; R. Zeiser; G. Ihorst; J. Finke; C. I. Müller 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 512 KB

Dose-intensive first-line chemotherapy w

Dose-intensive first-line chemotherapy with epirubicin and continuous infusion ifosfamide in adult patients with advanced soft tissue sarcomas: a phase II study

✍ R Palumbo; C Neumaier; M Cosso; G Bertero; P Raffo; N Spadini; S Valente; G Vill 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Induction, mobilization of peripheral bl

Induction, mobilization of peripheral blood stem cells (PBSC), high-dose chemotherapy and PBSC infusion in patients with untreated stage IV breast cancer: outcomes by intent to treat analyses

✍ Weaver, C H; West, W H; Schwartzberg, L S; Alberico, T; Leff, R; Greco, F A; Hai 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 133 KB

A phase I/II study of sequential, dose-e

A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas

✍ Carsten Bokemeyer; Anke Franzke; Jörg T. Hartmann; Christoph Schöber; Lubomir Ar 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

ide combined with full dose doxorubicin chemotherapy supported with peripheral blood stem cells (PBSC) and granulocyte-colony stimulating factor (G-CSF) in

Palifermin reduces severe oral mucositis

Palifermin reduces severe oral mucositis (OM), improves patient quality of life, and reduces health resource use in patients with hematologic malignancies receiving high-dose chemotherapy (HDCT) and total body irradiation (TBI) with autologous peripheral blood stem cell (PBSC) support: results from a phase III trial

✍ W. Bensinger; D. Weisdorf; T. Gentile; A. Cesano; D. Elhardt; C. Emmanouilides; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Long term results of a phase II trial of

Long term results of a phase II trial of Induction Chemotherapy with Uracil-Ftegafur (UFT), Vinorelbine and Cisplatin (UFTVP) followed by Radiotherapy concomitant with UFT and Carboplatin (RT/UFTJ) in Non-Resectable Locally Advanced (Stage IV-B) Squamous Cell Head and Neck Carcinoma and Peripheral Blood Stem Cell Support (PBSCS) with Febrile Neutropenia

✍ Fernando Rivera; María E Vega-Villegas; Marta F. López-Brea; Almudena García-Cas 📂 Article 📅 2007 🏛 Springer Milan 🌐 Spanish ⚖ 650 KB